Window on financial developments in chemical industries

Desai, Suresh Thakur
March 2005
Chemical Business;Mar2005, Vol. 19 Issue 3, p47
Trade Publication
Provides an account of financial developments in chemical industries in India as of March 2005. Financial performance of the Asian Paints for the quarter ended December 31, 2004; Swap ratio for the merger between the Bharat Petroleum and Kochi Refineries; Net profit posted by Dr. Reddy's Laboratories for the third quarter ended December 31, 2004.


Related Articles

  • Dr Reddy's laboratories net up by 45%. Desai, Suresh Thakur // Chemical Business;May/Jun98, Vol. 12 Issue 5/6, p98 

    Cites the financial results for Dr. Reddy's Laboratories during the fiscal period 1997-98.

  • Dr Reddy's Inks commercialisation Deal with Hatchtech.  // eHEALTH;9/16/2015, p1 

    The article reports on the commercialization contract signed by pharmaceutical company Dr. Reddy's Laboratories Ltd. with Australian pharmaceutical company Hatchtech Pty. Ltd., for the development of an innovative prescription head lice product Xeglyze lotion.

  • BPCL plans Rs 5,000 cr investment in Kochi Refineries.  // Chemical Business;Sep2006, Vol. 20 Issue 9, p68 

    The article reports on the plans of Bharat Petroleum Corp. Ltd. to invest money in the newly merged Kochi Refineries Ltd. in 2006. The investment plans include the construction of a polypropylene plant, quality upgrade at its bitumen plant and increase production capacity by 2009. The combined...

  • BPCL posts Rs 2,625 cr loss in Sept quarter.  // Chemical Business;Nov2008, Vol. 22 Issue 11, p68 

    The article reports on the loss posted by Bharat Petroleum Corporation Ltd. (BPCL) for the quarter ended September 2008. The company reported a loss of about Rs 2.625.27 crore in the second quarter of the year. The company notes that high crude prices and large under recovery sale of diesel and...

  • Rhodia Deal the Latest in a String of API Acquisitions by Indian Firms. Scott, Alex // Chemical Week;1/18/2006, Vol. 168 Issue 2, p25 

    The article reports on acquisition deals in the pharmaceutical and fine chemicals industries as of January 18, 2006. The purchase of Rhodia Pharma Solutions by custom active pharmaceutical ingredients (API) producer Shasun Chemicals and Drugs is the latest in a wave of API acquisitions by Indian...

  • DRL to acquire BMS Laboratories and Meridian Healthcare UK.  // Pharmaceutical Technology Asia;Aug2002, p7 

    Focuses on an agreement signed by Dr Reddy's Laboratories (DRL) to acquire BMS Laboratories Limited and Meridian Healthcare. Impact of the agreement on the expansion efforts of DRL.

  • Beyond betapharm. Sharma, E. Kumar // Business Today;3/21/2010, Vol. 19 Issue 6, p90 

    The article focuses on the emergence of problems after the acquisition of German generics company betapharm Arzneimittel GmbH by Indian pharmaceutical company Dr. Reddy's Laboratories Ltd. It notes that the German government introduced healthcare sector reforms which converted branded generics...

  • OctoPlus Shares Surge After Dr. Reddy's $36M Buyout Bid. Sheridan, Cormac // BioWorld Today;10/23/2012, Vol. 23 Issue 206, p2 

    The article reports on the 27.4 million euro-cash buyout offer accepted by OctoPlus NV from Dr. Reddy's Laboratories Ltd. The event has pushed OctoPlus share price up by 23 percent. Dr. Reddy's is now planning to proceed with a recommended public offer for all the outstanding shares of OctoPlus....

  • Dr Reddy's ready to drive down costs. Cameron, Amanda // New Zealand Doctor;9/24/2008, p35 

    The article features Affordable Healthcare, a New Zealand company acquired by Indian generics manufacturer Dr. Reddy in April 2008. Affordable Healthcare was created in 2003 as a distributor of Dr. Reddy's products and was later set-up for acquisition by Dr. Reddy. Affordable Healthcare won the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics